Holdings
T. Rowe Price Health Sciences Fund, Inc.
As of Jun 30, 2026, T. Rowe Price Health Sciences Fund, Inc. reported 161 positions worth US$11.2B. Largest: Eli Lilly and Company, Johnson & Johnson and UnitedHealth Group Incorporated. What it bought and sold, with each filing.
Holdings
- Part of
- T. Rowe Price
- Positions
- 161
- Value as reported
- US$11.2B
- Holdings as of
- Jun 30, 2026
- Last filed
- Aug 27, 2026
| Company | Shares | Value as reported | % of portfolio | Change | As of |
|---|---|---|---|---|---|
| Eli Lilly and Company NYSE:LLY | 1.42M | US$1.71B | 14.3% | +222K | Jun 30, 2026 |
| Johnson & Johnson NYSE:JNJ | 3.12M | US$792M | 6.6% | +2.03M | Jun 30, 2026 |
| UnitedHealth Group Incorporated NYSE:UNH | 1.72M | US$716M | 6.0% | +479K | Jun 30, 2026 |
| AbbVie Inc. NYSE:ABBV | 2.42M | US$609M | 5.1% | +998K | Jun 30, 2026 |
| Merck & Company, Inc. NYSE:MRK | 3.73M | US$479M | 4.0% | +609K | Jun 30, 2026 |
| Gilead Sciences, Inc. NASDAQ:GILD | 2.67M | US$337M | 2.8% | +633K | Jun 30, 2026 |
| Thermo Fisher Scientific Inc NYSE:TMO | 601K | US$301M | 2.5% | −300K | Jun 30, 2026 |
| Vertex Pharmaceuticals Incorporated NASDAQ:VRTX | 548K | US$272M | 2.3% | −43,160 | Jun 30, 2026 |
| Bristol-Myers Squibb Company NYSE:BMY | 4.37M | US$252M | 2.1% | New | Jun 30, 2026 |
| Abbott Laboratories NYSE:ABT | 2.48M | US$225M | 1.9% | New | Jun 30, 2026 |
| Intuitive Surgical, Inc. NASDAQ:ISRG | 563K | US$224M | 1.9% | −301K | Jun 30, 2026 |
| Amgen Inc. NASDAQ:AMGN | 600K | US$217M | 1.8% | +296K | Jun 30, 2026 |
| Stryker Corporation NYSE:SYK | 676K | US$213M | 1.8% | −471K | Jun 30, 2026 |
| Elevance Health, Inc. NYSE:ELV | 472K | US$183M | 1.5% | +228K | Jun 30, 2026 |
| Natera, Inc. NASDAQ:NTRA | 632K | US$172M | 1.4% | +70,400 | Jun 30, 2026 |
| Danaher Corporation NYSE:DHR | 894K | US$170M | 1.4% | −282K | Jun 30, 2026 |
| Guardant Health, Inc. NASDAQ:GH | 976K | US$146M | 1.2% | −80,400 | Jun 30, 2026 |
| Cardinal Health, Inc. NYSE:CAH | 519K | US$123M | 1.0% | +171K | Jun 30, 2026 |
| Royalty Pharma plc NASDAQ:RPRX | 2.06M | US$116M | 0.97% | +820K | Jun 30, 2026 |
| CVS Health Corporation NYSE:CVS | 1.08M | US$112M | 0.94% | −228K | Jun 30, 2026 |
| Tenet Healthcare Corporation NYSE:THC | 598K | US$112M | 0.94% | +18,200 | Jun 30, 2026 |
| Kymera Therapeutics, Inc. NASDAQ:KYMR | 925K | US$106M | 0.89% | −77,400 | Jun 30, 2026 |
| Protagonist Therapeutics, Inc. NASDAQ:PTGX | 829K | US$102M | 0.85% | −314K | Jun 30, 2026 |
| Moderna, Inc. NASDAQ:MRNA | 1.41M | US$98.9M | 0.83% | +885K | Jun 30, 2026 |
| BrightSpring Health Services, Inc. NASDAQ:BTSG | 1.41M | US$98.3M | 0.82% | −1.1M | Jun 30, 2026 |
| Revolution Medicines, Inc. NASDAQ:RVMD | 495K | US$92.8M | 0.78% | −1.02M | Jun 30, 2026 |
| Roivant Sciences Ltd. NASDAQ:ROIV | 2.37M | US$84M | 0.70% | −2.08M | Jun 30, 2026 |
| Alnylam Pharmaceuticals, Inc. NASDAQ:ALNY | 266K | US$80.2M | 0.67% | −266K | Jun 30, 2026 |
| Viatris Inc. NASDAQ:VTRS | 4.95M | US$78.6M | 0.66% | +4.02M | Jun 30, 2026 |
| Charles River Laboratories International, Inc. NYSE:CRL | 326K | US$74M | 0.62% | +247K | Jun 30, 2026 |
| argenx SE EURONEXT:ARGX | 76,622 | US$71.1M | 0.60% | −359K | Jun 30, 2026 |
| Edwards Lifesciences Corporation NYSE:EW | 780K | US$70.6M | 0.59% | +218K | Jun 30, 2026 |
| Centene Corporation NYSE:CNC | 1.06M | US$67.9M | 0.57% | +529K | Jun 30, 2026 |
| Spyre Therapeutics, Inc. NASDAQ:SYRE | 712K | US$63.2M | 0.53% | −142K | Jun 30, 2026 |
| Definium Therapeutics, Inc. NASDAQ:DFTX | 1.29M | US$60.6M | 0.51% | New | Jun 30, 2026 |
| Insmed Incorporated NASDAQ:INSM | 548K | US$58.5M | 0.49% | −154K | Jun 30, 2026 |
| Twist Bioscience Corporation NASDAQ:TWST | 555K | US$57.1M | 0.48% | New | Jun 30, 2026 |
| Chugai Pharmaceutical Co., Ltd. TSE:4519 | 1.17M | US$54.1M | 0.45% | +30,600 | Jun 30, 2026 |
| AstraZeneca PLC LSE:AZN | 279K | US$52.9M | 0.44% | −1.47M | Jun 30, 2026 |
| United Therapeutics Corporation NASDAQ:UTHR | 96,653 | US$52.4M | 0.44% | −150K | Jun 30, 2026 |
| Krystal Biotech, Inc. NASDAQ:KRYS | 139K | US$51.6M | 0.43% | −135K | Jun 30, 2026 |
| Boston Scientific Corporation NYSE:BSX | 1.2M | US$51.1M | 0.43% | −407K | Jun 30, 2026 |
| Medtronic plc. NYSE:MDT | 630K | US$49.3M | 0.41% | New | Jun 30, 2026 |
| Erasca, Inc. NASDAQ:ERAS | 2.58M | US$47.3M | 0.40% | +1.34M | Jun 30, 2026 |
| BillionToOne, Inc. NASDAQ:BLLN | 378K | US$45.3M | 0.38% | +113K | Jun 30, 2026 |
| Praxis Precision Medicines, Inc. NASDAQ:PRAX | 133K | US$44.6M | 0.37% | −55,981 | Jun 30, 2026 |
| Medpace Holdings, Inc. NASDAQ:MEDP | 84,145 | US$44.6M | 0.37% | +61,213 | Jun 30, 2026 |
| Monte Rosa Therapeutics, Inc. NASDAQ:GLUE | 1.82M | US$44.1M | 0.37% | −45,900 | Jun 30, 2026 |
| Tango Therapeutics, Inc. NASDAQ:TNGX | 1.4M | US$43.8M | 0.37% | +763K | Jun 30, 2026 |
| Oruka Therapeutics, Inc. NASDAQ:ORKA | 451K | US$42.9M | 0.36% | −24,900 | Jun 30, 2026 |
| Ascendis Pharma A/S NASDAQ:ASND | 160K | US$42.6M | 0.36% | −516K | Jun 30, 2026 |
| BeOne Medicines Ltd. Class A SSE:688235 | 153K | US$42.3M | 0.35% | −336K | Jun 30, 2026 |
| Humana Inc. NYSE:HUM | 106K | US$42.2M | 0.35% | New | Jun 30, 2026 |
| Dianthus Therapeutics, Inc. NASDAQ:DNTH | 429K | US$41.8M | 0.35% | −54,000 | Jun 30, 2026 |
| Scholar Rock Holding Corporation NASDAQ:SRRK | 738K | US$40.6M | 0.34% | −632K | Jun 30, 2026 |
| Kodiak Sciences Inc NASDAQ:KOD | 1.01M | US$39.5M | 0.33% | +92,200 | Jun 30, 2026 |
| Axsome Therapeutics, Inc. NASDAQ:AXSM | 151K | US$37M | 0.31% | −12,700 | Jun 30, 2026 |
| Summit Therapeutics Inc. NASDAQ:SMMT | 2.53M | US$36.9M | 0.31% | −3.42M | Jun 30, 2026 |
| Novo Nordisk A/S Class B OMXCOP:NOVO_B | 762K | US$36.1M | 0.30% | +325K | Jun 30, 2026 |
| Regeneron Pharmaceuticals, Inc. NASDAQ:REGN | 55,661 | US$34.7M | 0.29% | −318K | Jun 30, 2026 |
| Relay Therapeutics, Inc. NASDAQ:RLAY | 1.84M | US$34.4M | 0.29% | +541K | Jun 30, 2026 |
| Ionis Pharmaceuticals, Inc. NASDAQ:IONS | 434K | US$34.4M | 0.29% | −449K | Jun 30, 2026 |
| Cytokinetics, Incorporated NASDAQ:CYTK | 395K | US$33.7M | 0.28% | −268K | Jun 30, 2026 |
| Vera Therapeutics, Inc. NASDAQ:VERA | 784K | US$33.7M | 0.28% | −452K | Jun 30, 2026 |
| Enliven Therapeutics, Inc. NASDAQ:ELVN | 647K | US$32.9M | 0.28% | +594K | Jun 30, 2026 |
| Agilent Technologies, Inc. NYSE:A | 245K | US$32.5M | 0.27% | New | Jun 30, 2026 |
| MBX Biosciences, Inc. NASDAQ:MBX | 586K | US$32.4M | 0.27% | −135K | Jun 30, 2026 |
| CG Oncology, Inc. NASDAQ:CGON | 438K | US$31.1M | 0.26% | −671K | Jun 30, 2026 |
| NewAmsterdam Pharma Company N.V. NASDAQ:NAMS | 913K | US$30.9M | 0.26% | New | Jun 30, 2026 |
| Waters Corporation NYSE:WAT | 81,880 | US$30.7M | 0.26% | New | Jun 30, 2026 |
| Crinetics Pharmaceuticals, Inc. NASDAQ:CRNX | 813K | US$30.4M | 0.25% | −281K | Jun 30, 2026 |
| Madrigal Pharmaceuticals, Inc. NASDAQ:MDGL | 56,364 | US$30.3M | 0.25% | −18,359 | Jun 30, 2026 |
| Liquidia Corporation NASDAQ:LQDA | 365K | US$29.1M | 0.24% | +104K | Jun 30, 2026 |
| Mirum Pharmaceuticals, Inc. NASDAQ:MIRM | 248K | US$29M | 0.24% | +22,600 | Jun 30, 2026 |
| Beam Therapeutics Inc. NASDAQ:BEAM | 842K | US$28.9M | 0.24% | −252K | Jun 30, 2026 |
| Nurix Therapeutics, Inc. NASDAQ:NRIX | 1.19M | US$28.8M | 0.24% | −28,513 | Jun 30, 2026 |
| West Pharmaceutical Services, Inc. NYSE:WST | 77,225 | US$27.7M | 0.23% | −20,400 | Jun 30, 2026 |
| IDEAYA Biosciences, Inc. NASDAQ:IDYA | 727K | US$27.1M | 0.23% | +468K | Jun 30, 2026 |
| BridgeBio Pharma, Inc. NASDAQ:BBIO | 363K | US$27.1M | 0.23% | −501K | Jun 30, 2026 |
| Teva Pharmaceutical Industries Limited TASE:TEVA | 795K | US$26.9M | 0.23% | New | Jun 30, 2026 |
| Rhythm Pharmaceuticals, Inc. NASDAQ:RYTM | 242K | US$26.8M | 0.22% | No change | Jun 30, 2026 |
| Viridian Therapeutics, Inc. NASDAQ:VRDN | 1.45M | US$26.6M | 0.22% | +1.1M | Jun 30, 2026 |
| Alkermes plc NASDAQ:ALKS | 504K | US$26.4M | 0.22% | New | Jun 30, 2026 |
| Alignment Healthcare, Inc. NASDAQ:ALHC | 1.07M | US$25.4M | 0.21% | −410K | Jun 30, 2026 |
| Vaxcyte, Inc. NASDAQ:PCVX | 426K | US$24.8M | 0.21% | +111K | Jun 30, 2026 |
| Rapport Therapeutics, Inc. NASDAQ:RAPP | 572K | US$23.8M | 0.20% | −29,200 | Jun 30, 2026 |
| Immunome, Inc. NASDAQ:IMNM | 1.09M | US$23.2M | 0.19% | −573K | Jun 30, 2026 |
| Palvella Therapeutics, Inc. NASDAQ:PVLA | 144K | US$22M | 0.18% | −8,900 | Jun 30, 2026 |
| Climb Bio, Inc. NASDAQ:CLYM | 1.64M | US$21.3M | 0.18% | +168K | Jun 30, 2026 |
| ICON plc NASDAQ:ICLR | 120K | US$20.9M | 0.17% | New | Jun 30, 2026 |
| Kailera Therapeutics, Inc. NASDAQ:KLRA | 904K | US$19.9M | 0.17% | New | Jun 30, 2026 |
| Celldex Therapeutics, Inc. NASDAQ:CLDX | 495K | US$18.4M | 0.15% | +72,376 | Jun 30, 2026 |
| Bicara Therapeutics Inc. NASDAQ:BCAX | 591K | US$17.5M | 0.15% | −51,500 | Jun 30, 2026 |
| Cencora, Inc. NYSE:COR | 61,157 | US$17.3M | 0.14% | −119K | Jun 30, 2026 |
| Sonova Holding AG SIX:SOON | 72,348 | US$17.2M | 0.14% | −33,185 | Jun 30, 2026 |
| Alumis Inc. NASDAQ:ALMS | 595K | US$16.7M | 0.14% | −594K | Jun 30, 2026 |
| Apogee Therapeutics, Inc. NASDAQ:APGE | 126K | US$16.7M | 0.14% | −429K | Jun 30, 2026 |
| ORIC Pharmaceuticals, Inc. NASDAQ:ORIC | 1.53M | US$16.6M | 0.14% | −207K | Jun 30, 2026 |
| Veeva Systems Inc. NYSE:VEEV | 91,000 | US$16.1M | 0.14% | New | Jun 30, 2026 |
| MoonLake Immunotherapeutics NASDAQ:MLTX | 792K | US$15.4M | 0.13% | −94,957 | Jun 30, 2026 |
This page holds 100 of 161 positions.